Huijuan Jiang
154 Anshan St
Tianjin, China
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
A survival prognostic model for high-risk myelodysplastic syndrome patients treated with decitabine.
A survival prognostic model for high-risk myelodysplastic syndrome patients treated with decitabine.
Journal: Hematology (Amsterdam, Netherlands)
Published: April 13, 2026
Cyclosporine A improves survival in lower-risk hypoplastic myelodysplastic syndromes: a single-center retrospective study from China.
Journal: Hematology (Amsterdam, Netherlands)
Published: December 18, 2025
The Landscape of Primary Central Nervous System Lymphoma (PCNSL): Clinicopathologic and Genomic Characteristics and Therapeutic Perspectives.
Journal: Cancers
Published: July 18, 2025
Zanubrutinib, lenalidomide, rituximab, temozolomide ± methotrexate as first-line treatment for primary central nervous system lymphoma: A prospective, open-label, multicentre clinical trial.
Journal: British journal of haematology
Published: July 03, 2025
Gut Microbiome and Plasma Metabolomic Analysis in Patients with Myelodysplastic Syndrome.
Journal: Oxidative medicine and cellular longevity
Published: December 16, 2021
Impact of iron overload by transfusion on survival and leukemia transformation of myelodysplastic syndromes in a single center of China.
Journal: Hematology (Amsterdam, Netherlands)
Published: November 10, 2021
Increased myeloid-derived suppressor cells in patients with myelodysplastic syndromes suppress CD8+ T lymphocyte function through the STAT3-ARG1 pathway.
Journal: Leukemia & lymphoma
Published: September 28, 2020
Transcriptional programming drives Ibrutinib-resistance evolution in mantle cell lymphoma.
Journal: Cell reports
Published: July 30, 2020
Abnormal Ferroptosis in Myelodysplastic Syndrome.
Journal: Frontiers in oncology
Published: May 28, 2020
Abnormal platelet phenotypes in patients with myelodysplastic syndromes.
Journal: International journal of laboratory hematology
Published: August 28, 2019
Decitabine shows synergistic effects with arsenic trioxide against myelodysplastic syndrome cells via endoplasmic reticulum stress-related apoptosis.
Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research
Published: February 16, 2019
Last Updated: 09/26/2026